{"id":"https://openalex.org/W4321482425","doi":"https://doi.org/10.1159/000529714","title":"Eine einzigartige dreifache Philadelphia Chromosom-Variante t(4;9;22)(q21;q34;q11.2) bei einem neu diagnostizierten Patienten mit chronischer myeloischer Leuk\u00e4mie in chronischer Phase","display_name":"Eine einzigartige dreifache Philadelphia Chromosom-Variante t(4;9;22)(q21;q34;q11.2) bei einem neu diagnostizierten Patienten mit chronischer myeloischer Leuk\u00e4mie in chronischer Phase","publication_year":2023,"publication_date":"2023-01-01","ids":{"openalex":"https://openalex.org/W4321482425","doi":"https://doi.org/10.1159/000529714"},"language":"de","primary_location":{"id":"doi:10.1159/000529714","doi":"https://doi.org/10.1159/000529714","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000529714","pdf_url":null,"source":{"id":"https://openalex.org/S4210195348","display_name":"Kompass Onkologie","issn_l":"2296-5386","issn":["2296-5386","2296-5416"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kompass Onkologie","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1159/000529714","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Yuka Torii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuka Torii","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028975994","display_name":"Kana Nanjo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kana Nanjo","raw_affiliation_strings":["Faculty of Medicine, Yamagata University., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Yamagata University., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071643003","display_name":"Tomomi Toubai","orcid":"https://orcid.org/0000-0001-6658-7543","observed_orcids":["https://orcid.org/0000-0001-6658-7543"]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomomi Toubai","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019813816","display_name":"Masashi Hosokawa","orcid":"https://orcid.org/0000-0003-1755-3173","observed_orcids":["https://orcid.org/0000-0003-1755-3173"]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masashi Hosokawa","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101863822","display_name":"Ryo Sato","orcid":"https://orcid.org/0009-0008-6569-5786","observed_orcids":["https://orcid.org/0009-0008-6569-5786"]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryo Sato","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085488734","display_name":"Akane Yamada","orcid":"https://orcid.org/0000-0002-8395-7646","observed_orcids":["https://orcid.org/0000-0002-8395-7646"]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akane Yamada","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052872072","display_name":"Keiko Aizawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiko Aizawa","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025786070","display_name":"Masahito Himuro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahito Himuro","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010592652","display_name":"Satoshi Ito","orcid":"https://orcid.org/0009-0001-8984-5215","observed_orcids":["https://orcid.org/0009-0001-8984-5215"]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Ito","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001076934","display_name":"Masakazu Yamamoto","orcid":"https://orcid.org/0000-0001-6027-620X","observed_orcids":["https://orcid.org/0000-0001-6027-620X"]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masakazu Yamamoto","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":"https://orcid.org/0000-0001-6027-620X","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009204664","display_name":"John Martin Magenau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Magenau","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School., Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School., Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020537159","display_name":"Ryan A. Wilcox","orcid":"https://orcid.org/0000-0002-6420-0760","observed_orcids":["https://orcid.org/0000-0002-6420-0760"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Wilcox","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School., Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School., Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056287200","display_name":"Kenichi Ishizawa","orcid":"https://orcid.org/0000-0003-4911-8889","observed_orcids":["https://orcid.org/0000-0003-4911-8889","https://orcid.org/0009-0004-5182-4832"]},"institutions":[{"id":"https://openalex.org/I112524849","display_name":"Yamagata University","ror":"https://ror.org/00xy44n04","country_code":"JP","type":"education","lineage":["https://openalex.org/I112524849"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenichi Ishizawa","raw_affiliation_strings":["Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University faculty of Medicine, 2-2-2 Iida-Nishi 990-9585., Yamagata, Japan","institution_ids":["https://openalex.org/I112524849"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.03282744,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"1","first_page":"51","last_page":"54"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11213","display_name":"Genomic variations and chromosomal abnormalities","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9070000052452087},{"id":"https://openalex.org/keywords/philadelphia-chromosome","display_name":"Philadelphia chromosome","score":0.8180000185966492},{"id":"https://openalex.org/keywords/bcr-abl-fusion","display_name":"BCR-ABL fusion gene","score":0.7919999957084656},{"id":"https://openalex.org/keywords/chromosome-4q21","display_name":"chromosome 4q21","score":0.8309999704360962},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9470000267028809},{"id":"https://openalex.org/keywords/bosutinib","display_name":"bosutinib","score":0.9769999980926514},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chronic-phase","display_name":"chronic phase","score":0.6690000295639038},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.3580000102519989}],"concepts":[{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.6179938316345215},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5933140516281128}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1159/000529714","doi":"https://doi.org/10.1159/000529714","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000529714","pdf_url":null,"source":{"id":"https://openalex.org/S4210195348","display_name":"Kompass Onkologie","issn_l":"2296-5386","issn":["2296-5386","2296-5416"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kompass Onkologie","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1159/000529714","doi":"https://doi.org/10.1159/000529714","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000529714","pdf_url":null,"source":{"id":"https://openalex.org/S4210195348","display_name":"Kompass Onkologie","issn_l":"2296-5386","issn":["2296-5386","2296-5416"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kompass Onkologie","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.5,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W2048182022","https://openalex.org/W2604872355"],"abstract_inverted_index":{"Hintergrund:":[0],"Die":[1,102],"chronische":[2,95],"myeloische":[3],"Leuk\u00e4mie":[4,49,59,75,97],"ist":[5],"eine":[6,94],"h\u00e4matologische":[7],"Malignit\u00e4t,":[8],"die":[9,171],"mit":[10,46,56,90,110,162,182],"der":[11,44,54,77,88,136,146,149,156,161,183],"Fusion":[12,21],"von":[13,139],"zwei":[14],"Genen":[15],"einhergeht:":[16],"BCR":[17],"und":[18,30,112,119,155,176],"ABL1.":[19],"Diese":[20],"resultiert":[22],"aus":[23],"einer":[24,69,143],"Translokation":[25],"zwischen":[26],"den":[27],"Chromosomen":[28],"9":[29],"22,":[31],"auch":[32],"als":[33,42],"Philadelphia":[34],"Chromosom":[35,151],"bekannt.":[36],"Obwohl":[37],"das":[38,150],"Philadelphia-Chromosom":[39],"bei":[40,72,148],"mehr":[41],"90%":[43],"Patienten":[45,55],"chronischer":[47,57,73,99],"myeloischer":[48,58,74],"vorhanden":[50],"ist,":[51,154],"weisen":[52],"5-8%":[53],"komplexe":[60],"Translokationsvarianten":[61],"auf.":[62],"Wir":[63,166],"berichten":[64],"hier":[65],"\u00fcber":[66,170],"einen":[67],"Fall":[68,138],"dreifachen":[70],"Translokationsvariante":[71],"in":[76,98],"chronischen":[78],"Phase.":[79],"Vorstellung":[80],"des":[81],"Falles:":[82],"Bei":[83],"einem":[84],"40-j\u00e4hrigen":[85],"asiatischen":[86],"Mann,":[87],"sich":[89],"Leukozytose":[91],"vorstellte,":[92],"wurde":[93,108,125],"myeloischen":[96],"Phase":[100],"diagnostiziert.":[101],"zytogenetische":[103],"Karyotypisierungsanalyse":[104],"ergab":[105],"46,XY,t(4;9;22)(q21;q34;q11.2).":[106],"Er":[107],"behandelt":[109,164],"Bosutinib":[111],"dann":[113],"wegen":[114],"Unvertr\u00e4glichkeit":[115],"auf":[116],"Dasatinib":[117],"umgestellt,":[118],"nach":[120],"17":[121],"Monaten":[122],"kontinuierlicher":[123],"Behandlung":[124],"MR4,5":[126],"(BCR-ABL/ABL":[127],"\u2264":[128],"0,0032%,":[129],"internationale":[130],"Skala)":[131],"erreicht.":[132],"Schlussfolgerung:":[133],"Dies":[134],"war":[135],"14.":[137],"t(4;9;22),":[140],"im":[141],"Speziellen":[142],"neue":[144],"Variante":[145],"Ph-Translokation,":[147],"4q21":[152],"beteiligt":[153],"erste":[157],"weltweit":[158],"erfolgreiche":[159],"Fall,":[160],"Tyrosinkinase-Inhibitoren":[163],"wurde.":[165],"fassen":[167],"fr\u00fchere":[168],"Fallberichte":[169],"dreifache":[172],"Chromosomenverschiebung":[173],"t(4;9;22)":[174],"zusammen":[175],"er\u00f6rtern,":[177],"wie":[178],"diese":[179],"seltene":[180],"Verschiebung":[181],"Prognose":[184],"zusammenh\u00e4ngt.":[185]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}